S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 97.5 TWD -0.51% Market Closed
Market Cap: 11.7B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

Relative Value

The Relative Value of one SCI Pharmtech Inc stock under the Base Case scenario is 47.69 TWD. Compared to the current market price of 97.5 TWD, SCI Pharmtech Inc is Overvalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
47.69 TWD
Overvaluation 51%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
16
Median 3Y
9.4
Median 5Y
8.7
Industry
2.5
vs History
15
vs Industry
11
Median 3Y
39.9
Median 5Y
34.5
Industry
21.9
vs History
6
vs Industry
20
Median 3Y
35.8
Median 5Y
22.2
Industry
16.5
vs History
vs Industry
Median 3Y
-29.9
Median 5Y
-14.2
Industry
23.6
vs History
80
vs Industry
37
Median 3Y
2.4
Median 5Y
2.3
Industry
2.1
vs History
50
vs Industry
15
Median 3Y
9.6
Median 5Y
8.7
Industry
2.6
vs History
46
vs Industry
6
Median 3Y
34.4
Median 5Y
30.7
Industry
5.2
vs History
53
vs Industry
9
Median 3Y
37.8
Median 5Y
32.9
Industry
13.3
vs History
39
vs Industry
4
Median 3Y
80.8
Median 5Y
58.7
Industry
16.6
vs History
6
vs Industry
21
Median 3Y
36.9
Median 5Y
22
Industry
15.6
vs History
vs Industry
Median 3Y
-13.7
Median 5Y
-10.6
Industry
19.1
vs History
84
vs Industry
38
Median 3Y
2
Median 5Y
2
Industry
1.9

Multiples Across Competitors

Competitors Multiples
SCI Pharmtech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
SCI Pharmtech Inc
TWSE:4119
11.7B TWD 9.3 84.2 34.8 80.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.7 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
TW
S
SCI Pharmtech Inc
TWSE:4119
Average P/E: 38.9
84.2
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.7
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top